Iwona Ługowska

11PUBLICATIONS
132CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological modellingLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 30, 2026
Feasibility and activity of concurrent neoadjuvant chemotherapy and radiation therapy in patients with high-risk soft tissue sarcoma.

|May 15, 2026
Trastuzumab deruxtecan in HER2-expressing gynecologic cancers from DESTINY-PanTumor02: antitumor activity, safety, and exploratory biomarker analyses.

|Oct 24, 2025
A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies.

Dejan Juric, Daniel Anderson, Afshin Dowlati

|Nov 09, 2024
Adjuvant Use of Pembrolizumab for Stage III Melanoma in a Real-World Setting in Europe.

Michael Weichenthal, Joanna Mangana, Iva Gavrilova

|Sep 11, 2024
Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02.

Ana Oaknin, Jung-Yun Lee, Vicky Makker

|Sep 04, 2024
The KEYVIBE program: vibostolimab and pembrolizumab for the treatment of advanced malignancies.

Ronnie Shapira-Frommer, Jiaxin Niu, Ruth Perets

Pageof 2

Frequent Collaborators

3 joint publications

Piotr Rutkowski

2 joint publications

Bohuslav Melichar

2 joint publications

Susana Banerjee

2 joint publications

Funda Meric-Bernstam